Professional Documents
Culture Documents
which expands on
the subjects so well outlined by Ginns BMJ series.
It is necessary to stress, however, that improve-
ments in prison health services even among the
member countries of the WHO Health in Prisons
Programme have been slow and are oen patchy.
They are highly dependent on government sup-
port, available resources, a press that is willing
to encourage a positive discussion of what needs
to be done, and a public that shows insight and
awareness. Above all, political will and leader-
ship are needed.
Ginns series of articles reminds us that prison
healthcare is not only a test of our civilisation
but also a real test of our medical professional-
ism. It is a test of whether health for all really
means all, and a test of our dedication to
tackling the complex health and social needs of
disadvantaged and vulnerable people. To build a
healthier society we need to move beyond focus-
ing on quality of care for individuals towards the
genuine support of human rights and enthusi-
asm for social justice, both of which underpin
the delivery of quality care to marginalised
populations.
Competing interests: None declared.
Provenance and peer review: Commissioned; not externally
peer reviewed.
References are in the version on bmj.com.
Cite this as: BMJ ;:f
ANALYSIS, p
Alex Gatherer temporary adviser to WHO Health in
Prisons Programme, Appleton, Warrington WA/ 'QD, UK
Alexgatherer@aol.com
It is too oen forgotten that prisoners are part of
society and that their health is an important public
health concern. Failure to pay due attention to the
health and social needs of prisoners is negligent,
undermines their human rights, and allows health
inequalities to persist. Prisons oen have old and
inadequate facilities, are overcrowded, contain
some of the most vulnerable people in society,
and tend towards poor regular data collection
and monitoring of health, which oen leads to
bypassing of health surveillance systems. All of
this means that they oen fail to carry out the rst
duty of public healththe protection of health.
Stephen Ginns series of ve articles on the
health of prisoners in England and Wales shone
a welcome spotlight on this problem.
-
The arti-
cles deal comprehensively with the main chal-
lenges that confront prison health and show the
complexity and wide range of ill health that can
exist. Most prisons have to cope with whoever is
sentenced by the courts and cannot choose which
prisoners they receive, even if they do not have
the facilities needed. Some progress has been
madefor example, in diverting prisoners with
serious mental illness to appropriate specialist
institutions. But specialist services are still patchy
and prisoners with other special needs are still
not cared for in specialist services. Prisoners with
drug and alcohol dependence need special treat-
ment, yet prisons are oen ill equipped to treat
these conditions.
The provision of healthcare to prisoners is far
from easy, even in countries such as England and
Wales, where prison health is part of the National
Health Service. Ginns rst article outlined clearly
the three main factors that make the protection
of health dicult in prison.
%
C
I
)
.
.
.
.
.
.
bmj.com/podcasts
OListen to a podcast about this
research paper
BMJ | 1 JUNE 2013 | VOLUME 346 13
RESEARCH
STUDY QUESTION What is the diagnostic value of
D-dimer testing in older patients with suspected venous
thromboembolism when the conventional cut-off value
is applied, and is the use of an age adjusted cut-off value
(age g/L in patients aged or more) a safe and more
efficient strategy?
SUMMARY ANSWER D-dimer testing is of limited utility
in older patients when the conventional cut-off value is
applied. Application of age adjusted cut-off values increases
the specificity without modifying the sensitivity, thereby
largely increasing the proportion of older patients with a
non-high clinical probability in whom imaging can be safely
avoided.
WHAT IS KNOWN AND WHAT THIS PAPER ADDS Since
D-dimer levels increase with age, D-dimer testing is less
useful to exclude venous thromboembolism in older
patients if the conventional cut-off value ( g/L) is used.
The specificity of D-dimer testing increased substantially
when the age adjusted cut-off value was applied and was
more than doubled in the eldest patients (> years).
This would result in imaging examinations being correctly
avoided in % to % of elderly patients with a non-high
probability of venous thromboembolism.
Selection criteria for studies
We searched Medline and Embase for studies published
before 21 June 2012 and contacted the authors of primary
studies. We selected studies that enrolled older patients
with suspected venous thromboembolism in whom
D-dimer testing (using both conventional (500 g/L) and
age adjusted (age10 g/L in patients aged >50 years)
cut-o values) and reference testing were performed. 22
tables were reconstructed and stratihed by age category
and D-dimer cut-o value.
Primary outcomes
Sensitivity and specihcity of D-dimer testing in patients
aged over 50 years.
Main results and role of chance
13 cohorts including 12 497 patients with a non-high
clinical probability were included in the meta-analysis.
The specihcity of the conventional cut-o value decreased
with increasing age, from 58% (95% conhdence interval
51% to 64%) in patients aged 51-60 years to 39% (34%
to 46%) in those aged 61-70 years, 25% (20% to 30%) in
those aged 71-80 years, and 15% (11% to 19%) in those
aged >80 years. Age adjusted cut-o values revealed higher
specihcities over all age categories: 62% (56% to 68%),
50% (43% to 56%), 44% (38% to 51%), and 35% (30% to
42%), respectively. Sensitivities of the age adjusted cut-o
remained above 97% in all age categories.
Bias, confounding, and other reasons for caution
The results of this meta-analysis are not applicable to
patients with a high clinical probability of venous throm-
boembolism, as additional imaging is warranted in these
patients to conhrm or refute the diagnosis, irrespective of
the D-dimer test results. Additional analyses showed that
the relative merit of application of the age adjusted instead
of the conventional cut-o value is higher in the case of
a low prevalence of venous thromboembolism compared
with a higher prevalence. We found some heterogeneity in
sensitivity and specihcity of D-dimer among studies, partly
explained by the application of dierent D-dimer assays. In
12 of the 13 included cohorts, venous thromboembolism
was excluded without imaging examination in patients
who were not at high risk, with a negative D-dimer (<500
g/L) test result and no recurrence of symptoms during
follow-up. This could have introduced small overestima-
tions of the diagnostic accuracy of the D-dimer test, as
small thrombi might have been missed in these patients.
Study funding/potential competing interests
This study was supported by the Netherlands Organization
for Scientihc Research. The authors were independent of
the funders for all aspects of the study.
Diagnostic accuracy of conventional or age adjusted D-dimer
cut-off values in older patients with suspected venous
thromboembolism: systematic review and meta-analysis
Henrike J Schouten,
1 l
G J Geersing,
1
H L Koek,
l
Nicolaas P A Zuithoff,
1
Kristel J M Janssen,
!
Rene A Douma,
/
Johannes J M van Delden,
1
Karel G M Moons,
1
Johannes B Reitsma
1
1
Julius Center for Health Sciences
and Primary Care, University Medical
Center Utrecht, PO Box S''uu,
!'uSGA Utrecht, Netherlands
l
Department of Geriatrics,
University Medical Center Utrecht,
Utrecht, Netherlands
!
Mapi Consultancy, Houten,
Netherlands
/
Department of Vascular Medicine,
Academic Medical Centre,
Amsterdam, Netherlands
Correspondence to: H J Schouten
h.j.schouten-@umcutrecht.nl
Cite this as: BMJ ;:f
doi: 1u.11!6/bmj.fl/9l
This is a summary of a paper that
was published on bmj.com as BMJ
lu1!;!/6:fl/9l
Pooled estimates of diagnostic accuracy of D-dimer testing in older patients suspected of having venous thromboembolism with a
non-high clinical probability, per age category and cut-off value ( study cohorts)
Age (years) No of patients
Pooled sensitivity (% CI) Pooled specificity (% CI)
Conventional cut-off (%) Age adjusted cut-off (%) Conventional cut-off (%) Age adjusted cut-off (%)
'u ''lS 97.6 (9'.u to 9S.9) NA 66.S (61.! to 7l.u) NA
'1-6u lu/! 1uu.u (NA) 99./ (97.! to 99.9) '7.6 ('1./ to 6!.6) 6l.! ('6.l to 6S.u)
61-7u 1S1' 99.u (96.7 to 99.7) 97.! (9!.S to 9S.S) !9./ (!!.' to /'.6) /9.' (/!.l to ''.S)
71-Su 1S/l 9S.7 (96.' to 99.') 97.! (9/.! to 9S.S) l/.' (lu.u to l9.7) //.l (!S.u to 'u.')
>Su 1l69 99.6 (96.9 to 99.9) 97.u (9l.9 to 9S.S) 1/.7 (11.! to 1S.6) !'.l (l9./ to /1.')
Age adjusted cut-off value (age'u g/L) does not apply (NA) to patients aged 'u years.
bmj.com
OResearch: Validation of two
age dependent D-dimer cut-ol
values for exclusion of deep
vein thrombosis in suspected
elderly patients in primary care:
retrospective, cross sectional
diagnostic analysis (BMJ
lu1l;!//:el9S')
OResearch: Excluding venous
thromboembolism using point of
care D-dimer tests in outpatients:
a diagnostic meta-analysis
(BMJ luu9;!!9:bl99u)
OResearch: Safe exclusion
of pulmonary embolism using
the Wells rule and qualitative
D-dimer testing in primary care:
prospective cohort study
(BMJ lu1l;!/':e6'6/)
14 BMJ | 1 JUNE 2013 | VOLUME 346
RESEARCH
Day of week of procedure and 30 day mortality for elective
surgery: retrospective analysis of hospital episode statistics
P Aylin,
R Alexandrescu,
M H Jen,
E K Mayer,
A Bottle
H
O
L
M
E
S
/
S
C
I
E
N
C
E
P
H
O
T
O
L
I
B
R
A
R
Y
18 BMJ | 1 JUNE 2013 | VOLUME 346
COMPENSATION
NHS, rather than of learning, innovation and
enthusiastic participation in improvement,
and warned that fear impedes learning and
dampens co-operation.
12
Vincent, a member of the Berwick advisory
panel, told the BMJ, If youve got people
saying I dont want to hear bad news, then
youve got a dangerous organisation immedi-
ately. He believes NHS organisations need to
mount their own safety programmes locally,
looking hard at whats going on day to day
rather than just responding to regulators. The
balance is wrong at the moment in the NHS.
We need more eort, more safety improvement
generated and led by clinicians and managers
in the organisations they work for, rather than
simply saying if weve met what the regulator
says then thats it, were safe.
Nevertheless, he hnds the transformation
in the landscape unbelievable since he
started working on healthcare safety in the
mid-1980s and is hopeful for the future. I
think whats happening now is were realis-
ing this is much tougher than people thought
and theres a certain realism coming across
the boardclinicians, managers, every-
bodybut no particular loss of eort. So Im
more optimistic now than I would have been
a few years ago.
Clare Dyer is legal correspondent, BMJ, London WC1H 9JR
claredyer@gmail.com
Competing interests: I have read and understood the BMJ
Group policy on declaration of interests and have no relevant
interests to declare.
Provenance and peer review: Commissioned; not externally
peer reviewed.
1 Bolsin S. Too many babies were damaged and dying.
Medical Harm lu11 July l7. http://medicalharm.org/
doctor-stories/stephen-bolsins-story-too-many-babies-
were-damaged-and-dying/.
l Kennedy I. Learning from Bristol: the report of the public
inquiry into childrens heart surgery at the Bristol Royal
Infirmary 19S/199'. HMSO, luu1.
! Francis R. Report of the Mid Staffordshire NHS Foundation
Trust public inquiry. lu1!. www.midstaffspublicinquiry.
com/report.
/ Department of Health. An organisation with a memory. DH,
luuu.
' Department of Health. Safety first: a report for patients,
clinicians and healthcare managers. DH, luu6.
6 NHS Litigation Authority. Report and accounts lu11-1l.
NHSLA, lu1l.
7 Haynes A, Weiser T, Berry W, Lipsitz SR, Breizat AH,
Dellinger EP, et al. A surgical safety checklist to reduce
morbidity and mortality in a global population. N Engl J Med
luu9;!6u:/91-9.
S House of Commons Health Committee. Patient safety.
Sixth report of session luuS/u9. HC1'1-1. luu9. www.
publications.parliament.uk/pa/cmluuSu9/cmselect/
cmhealth/1'1/1'1ul.htm.
9 Darzi A. High quality care for allNHS next stage review final
report. Department of Health, luuS.
1u NHS Litigation Authority. Ten years of maternity claims: an
analysis of NHS Litigation Authority data. NHSLA, lu1l.
11 Pasupathy D, Wood AM, Pell JP, Mechan H, Fleming M,
Smith GCS. Time of birth and risk of neonatal death at term:
retrospective cohort study. BMJ lu1u;!/1:c!/9S.
1l Institute for Healthcare Improvement. Achieving the
vision of excellence in quality. luuS. www.ajustnhs.com/
wp-content/uploads/lu1l/u9/IHI-report.pdf.
Cite this as: BMJ ;:f
and uncover appalling standards of care.
More attention is now being paid to mor-
tality data. Fourteen other trusts with higher
than expected mortality rates for two years are
being reviewed by a team headed by Keogh.
Brian Jarman, director of the Dr Foster Unit
and an adviser to the investigation into the
14 trusts, estimated in a BBC interview that
there had been tens of thousands of avoid-
able deaths in those hospitals alone over the
last 10 years.
Keogh pledged in April when giving the go
ahead for childrens heart surgery to resume
at Leeds, I want to be clear that NHS England
will do everything in its power to make sure
that measuring clinical outcomes will be given
priority in the new NHS. Organisations cannot
know they are providing eective or safe care
unless they are measuring and monitoring
their services. Heart surgeons have taken the
lead in publishing the outcomes of individual
surgeons, a move which has driven up stand-
ards. NHS Englands mandate for the next two
years includes shining a spotlight on variation
and unacceptable practice, starting with pub-
lishing outcomes in eight more surgical spe-
cialties as well as cardiology.
The quality, reliability, safety, and team-
work group at Oxford University is conduct-
ing a range of studies, including one looking
at ways of reducing preventable complications
of surgery. The unit is testing a range of inter-
ventions from other industriessuch as crew
resource management training from aviation,
lean manufacturing from process engineer-
ing at Toyota, and standard operating proce-
duresand applying them to healthcare.
At Mid Staffordshire, a key factor in the
dangerous care provided was inadequate
stamng levels, particularly of nurses, as the
trust strove to cut its dehcit to win founda-
tion trust status. And there are warning signs
that stamng is a more general problem. Legal
claims over birth errors cost the NHS E3.1bn
between 2000 and 2010, according to an
analysis by the NHS Litigation Authority.
10
Many claims arose from the interpretation of
cardiotocographs when women were cared
for by midwives alone or with junior doctors.
There is evidence that deliveries outside the
normal working week are associated with a
higher risk of neonatal death,
11
and the Royal
College of Obstetricians and Gynaecologists
has called for more consultants to be available
round the clock on labour wards. Information
governance puts hurdles in the way of linking
dierent NHS databases, but a research team
has applied for funding to look at the link
between time of birth and adverse outcomes
in England and Wales.
Risks are high with NHS trusts under pres-
sure to achieve cost savings at the same time
as the health service undergoes the largest
reorganisation in a generation. Yet the new
architecture, with a bigger role for clinicians
in commissioning healthcare services, could
provide another chance to put safety at the
heart of the NHS. Keogh has established a
reference group to identify how human fac-
tors could be embedded in the future NHS.
He told the hrst meeting, Weve been talking
about human factors for 10 years, but done
nothing . . . Given the current changes in the
NHS and the obvious need for improvement,
now is a good time to explore how we can
embed human factors in the new landscape.
Ending a culture of fear
The Department of Health has set up a new
national advisory panel on the safety of
patients, headed by Don Berwick, former
head of the US based Institute for Healthcare
Improvement and a world authority on patient
safety. The panel is due to report its recom-
mendations in July. Berwick will be working
with NHS England to ensure a robust safety
culture and a zero tolerance of avoidable harm
is embedded in the DNA of the NHS, the gov-
ernment has promised.
His key role holds out some hope of action
on what may be the biggest challengeensur-
ing that NHS sta can raise safety concerns
in the future without risking career suicide.
Berwicks team from the Institute for Health-
care Improvement produced a report for the
Department of Health in 2008, Achieving the
Vision of Excellence in Quality. It highlighted a
culture of fear and top-down control in the
Don Berwick highlighted a culture of fear and
top-down control in the NHS, rather than
of learning, innovation and enthusiastic
participation in improvement
BMJ | 1 JUNE 2013 | VOLUME 346 19
HEALTHCARE IN PRISONS
Promoting health
in prison
Prisons contain some of societys most disadvantaged people.
In the last of his series Stephen Ginn looks at how prison
provides opportunities to improve their health and asks
whether earlier intervention could keep them out of prison in
the first place
I
n previous articles I have set out the chal-
lenges of providing healthcare in prisons
and have examined the problems in British
prisons of elderly prisoners, women prison-
ers, and prisoners with mental disorders.
1-4
In this hnal article of the series I highlight how
prison contributes to the treatment of people who
are hard to reach.
Many British prisoners come from the most
economically deprived and socially disadvan-
taged groups within society. They share with
these groups the experience of being raised
in care, low educational attainment, unem-
ployment, and homelessness (table 1).
5
Some
minority ethnic groups are substantially over-
represented (table 2). Many prisoners have
chaotic lifestyles and complex health and social
problems. They may also have limited health
aspirations and low expectations of health
services, which may not have the exibility to
respond eectively to their needs.
7
Prison can provide an opportunity for the
orderly assessment and treatment of those whose
lifestyle has previously prevented engagement.
Prisoners can be encouraged to adopt healthier
behaviours, and prison can provide an oppor-
tunity to address health inequalities.
8
However,
prisons are not principally in the business of pro-
moting health and some people argue that there
is an inherent contradiction between the aims of
care and control.
9
Prisons have values, rules, and
rituals that enable prisoners to be observed, con-
tained, and disempowered
10
; these are at odds
with any notion that prisoners can be encour-
aged to take charge of their health.
9
In addition,
any discussion about the health of prisoners
cannot ignore the broader question of whether
prison is the right place for many oenders.
Health promotion in prison
The hrst dedicated health promotion strategy for
prisons in England and Wales was published in
2002.
8
Because few resources have been invested
in evaluating it, its impact is largely unknown.
11
12
In 2008-09 Her Majestys Inspectorate of Prisons
and the Care Quality Commission examined
a sample of 21 primary care trusts and found
that all undertook health promotion in prisons.
Although there was evidence of good practice,
the information on provision was not always suf-
hciently detailed to allow proper appraisal.
13
Around 80% of prisoners in England and
Wales smoke,
14
four times the proportion of the
general public.
15
Reasons for prisoners smok-
ing include relief from boredom and stress.
16
Smoking in UK prisons has been restricted since
2007: prisoners may smoke in their cells but are
not allowed to smoke in their workplace or dur-
ing educational programmes or activities.
17
The
governments 2010 tobacco control strategy for
Table | Social characteristics of prisoners
White Black Asian Mixed Chinese or other Unknown Total No
Population aged 1u years, luu9 SS.6 l.7 '.6 1./ 1.6 - /S /17 !/9
Stop and searches luu9-1u 67.l 1/.6 9.6 !.u 1.l /./ 1 1/1 S!9
Arrests luu9-1u 79.6 S.u '.6 l.9 1.' l./ 1 !S6 u!u
Cautions lu1u* S!.1 7.1 '.l 1.S l.S l!u 1u9
Court order supervisions lu1u S1.S 6.u /.9 l.S 1.! !.l 161 6S7
Prison population (including foreign nationals) lu1u 7l.u 1!.7 7.1 !.' 1./ l.l S' uul
*Data based on ethnic appearance and therefore do not include mixed category.
62% of prisoners on
directly observed therapy
[for TB] were homeless
on release, with less than
half completing a full
course of treatment
C
R
I
S
P
I
N
H
U
G
H
E
S
/
P
H
O
T
O
F
U
S
I
O
N
P
I
C
T
U
R
E
L
I
B
R
A
R
Y
BMJ | 1 JUNE 2013 | VOLUME 346 21
HEALTHCARE IN PRISONS
release care is variable, and continuity of care
can be poor.
41
Half of prisoners have no general
practitioner when they are released.
41
Former prisoners do not necessarily pri-
oritise their health on release, instead focusing
on basic needs such as accommodation .
38
In
a 2003 survey in England and Wales only two
thirds of adult prisoners said they had accom-
modation arranged for their release.
42
Broader
determinants of health such as poor prospects for
employment and lack of social
support are also problems.
38
Is this the only way?
Prison clearly has a part to play
in meeting the health needs of
a marginalised group of people.
However, it is ultimately not the
best place to tackle poor health. Some newspa-
pers delight in caricaturing prisons as holiday
camps,
43
but even if prisons shared some of
their characteristics, the harms of imprisonment
would remain. Custody separates families, and
former prisoners experience social disadvan-
tages such as a high unemployment rate.
5
Pris-
ons enforced passivity and conscious wasting of
life also cause acute distress.
44
The average yearly cost of a prison place in
England and Wales is E39 573.
45
In 2012 UK total
prison spend was E4.1bn.
46
Despite this expense,
prison does little to deter oending and almost
half of those sentenced to custody are reconvicted
within a year.
5
It is important to ask whether the
resources allocated to imprisonment could be
spent more wisely, whether custody is the best
way of dealing with people who oend, and how
prison numbers can be kept to a minimum.
People who commit crimes ohen come into
contact with health and social services because
of their problematic behaviour. Management
revolves around sanctions such as custody
47
rather than earlier assistance in the community
that might prevent a prison sentence. Innovative
thinking is required to allow resources currently
allocated to prisons to be deployed more con-
structively and at all stages of the lives of people
at risk of future imprisonment. Many of Britains
most vulnerable citizens now pass at some point
through the criminal justice system.
48
People in
the community with multiple needs and exclu-
sions have not been a government priority, and
there is no overarching strategy to tackle their
health and social needs
48
with the explicit aim
of avoiding custody.
Although recorded crime is falling,
49
the
number of British prisoners continues to climb.
Arguably, many of them should not be there. This
is because of the relative harmlessness of their
oences, the vulnerability of the oenders, and
the harmful consequences of imprisonment. This
is not to say that people who break the law should
not be punished, but that prison and punishment
should not be synonymous. Alternatives to prison
may oer better outcomes and save money. One
economic analysis found that community sen-
tences save E3437 to E88 469 per sentenced
oender, rising to as much as E200 000 if longer
term changes to oending patterns are also con-
sidered. Community based drug treatment was
found to be particularly eective at saving costs as
oenders receiving treatment were
43% less likely to re-offend after
release.
50
Court ordered commu-
nity sentences are reported to be 8%
more eective at reducing reoend-
ing rates than custodial sentences.
5
Continued and increasing reli-
ance on imprisonment is a moral
and political choice, a path that politicians
choose and society implicitly condones. During
1997-2009 the British government introduced
1036 new offences punishable by imprison-
ment
51
and the prison population in England and
Wales has almost doubled since the early 1990s.
1
Electorally, no major political party seems able
to abandon a populist stance of being tough on
crime. Yet everyone is aected by the increasing
human and economic costs of an ever more puni-
tive criminal justice system.
52
Stephen Ginn Roger Robinson editorial registrar, BMJ,
London WCH JR, UK
mail@stephenginn.com
Competing interests: I have read and understood the BMJ
Group policy on declaration of interests and have no relevant
interests to declare.
Provenance and peer review: Commissioned; not externally
peer reviewed,
References are in the version on bmj.com
Cite this as: BMJ ;:f
BMJ BLOG Peter Bailey
Galley slaves, rebel!
Jeremy Hunts speech to the Kings Fund
on May made me wonder if someone in
the Department of Health had had an Oh
my God! moment. His speech seemed
to suggest a dawning understanding that
those working in the front line of medicine in
general practice, the out of hours service, and
emergency departments are the good guys,
not the enemy. Slagging them off, starving
them of funds, setting impossible targets, and
beating them about the head with lurid stories
of failure has not, after all, improved the NHS.
The effect has instead been an erosion of
morale, a steady increase in morbid cynicism,
and a haemorrhage of talent away from the
beleaguered work places. Small wonder that
emergency medicine vacancies cannot be filled
and % of trainees leave the speciality. Who is
surprised that general practitioners over are
eyeing up the prospects for early retirement?
So, with this dreadful awakening to reality,
what is Jeremy Hunt actually saying? Is
he proposing a significant increase in the
workforce in primary care and emergency
medicine? Is he calling for longer appointments
in general practice?
No. Once again, the Department of Health
is asking for the impossible. Hunt said that
Every patient is the only patient. Is the man
mad? It is no longer possible to practice good
medicine in minute slots. The quick
patients are now seen by nurses, making the
case complexity of the people who consult the
doctors much greater.
He says that there has been a betrayal of
general practice ideals. The effrontery of
this is breathtaking. Is he trying to make us
feel guilty? Who exactly has committed this
betrayal? Who forced general practitioners
to give up in-house out of hours care by
imposing regulations that made it impossible
for individuals to meet targets designed for
corporate care providers? Who was it who said
that front line staff are coasting. Who erodes
practice income year on year while imposing
ever more onerous targets, slicing chunks off
resources and expecting us to run faster to stay
in the same place? We already feel like galley
slaves chained to the rowing bench, out in all
weathers, unable to attend to bodily functions,
whipped by the slave master, and working
endlessly to the beat of a merciless target drum.
So here is my advice to Mr Hunt: fund the
front line. Give us your support to give patients
more time. What we really want to do, Mr
Hunt, is to listen to the dying, the sick, and the
frightened and meet their needs. And we want
to be left alone to get on with it.
Peter Bailey is a freelance general practitioner,
Cambridge.
https://www.gov.uk/government/speeches/primary-
care-and-the-modern-family-doctor
The quality of planning
for post release care is
variable, and continuity
of care can be poor.
Half
of prisoners have no GP
when they are released
P
H
O
T
O
F
U
S
I
O
N
/
R
E
X
F
E
A
T
U
R
E
S
22 BMJ | 1 JUNE 2013 | VOLUME 346
22 BMJ | 1 JUNE 2013 | VOLUME 346
LETTERS
Letters are selected from rapid responses posted on bmj.com. Aher editing, all letters are
published online (www.bmj.com/archive/sevendays) and about half are published in print
To submit a rapid response go to any article on bmj.com and click respond to this article
plus third and fourth generation combined oral
contraceptives.
/
5
All eyes are on the EMAwill the precautionary
principle prevail and the lessons learnt from past
public health disasters be taken on board? Will
the agency follow suit, stick to its guns, and first,
do no harm?
3
Bruno Toussaint editorial director, Prescrire, Paris,
Cedex 11, France contact@prescrire.org
Competing interests: None declared.
1 European Medicines Agency. Refusal for the marketing
authorisation for Qsiva (phentermine/topiramate).
Questions and Answers. lu1!. www.ema.europa.eu/docs/
en_GB/document_library/Summary_of_opinion_-_Initial_
authorisation/human/uul!'u/WC'uu1!9l1'.pdf .
l Prescrire Editorial Staff. Topiramate+phentermine, an
excessively dangerous appetite-supressant combination.
Prescrire Int lu1!;ll:6/-7.
! Prescrire. Medicinal products used in weight control:
first, do no harm! lu1l. http://english.prescrire.org/
en/79/lu7//6!ul/l!7//133//SubReportDetails.aspx.
/ SCRIP. Fragrance or folly: 1' drug events will resolve before
April. Informa News ll February lu1!.
' European Medicines Agency. PRAC: Agendas, minutes and
highlights webpage. www.ema.europa.eu/ema/index.
jsp?curl=pages/about_us/document_listing/document_
listing_uuu!'!.jsp&mid=WCubu1acu'3u'al1cf.
Cite this as: BMJ ;:f
CALCIUM AND CARDIOVASCULAR RISK
What is the appropriate MHRA
regulatory response?
Concern has been expressed repeatedly in recent
years about inadequate oversight by regulatory
authorities of drugs and medical devices.
Recently, the Medicines and Healthcare Products
Regulatory Agency (MHRA) recommended
restricting the prescription of strontium ranelate
for osteoporosis.
1
This was because strontium
increased the risk of myocardial infarction
(relative risk 1.6, 95% CI 1.u7 to 2.38), although
it did not increase mortality, in a pooled analysis
of about 75uu participants in randomised
controlled trials.
Strontium is a divalent cation that mimics many
chemical and biological properties of calcium
and binds to the calcium receptor. Its effects on
fracture are similar to those of calcium. Strontium
decreases the risk of non-vertebral fractures by
1/% but does not prevent hip fractures.
2
Similarly,
calcium decreases the risk of total fractures by
12% but does not prevent hip fractures.
3
Calcium,
with or without vitamin D, also increased the risk
of myocardial infarction (1.25, 1.u8 to 1./5) in
pooled analyses of 13 trials (n=29 277).
/
The MHRAs response to the finding of
increased cardiovascular risk with calcium was
strikingly different from its response to that for
TELEHEALTH AND TELECARE
Over-claiming the evidence for
telehealth and telecare?
It would seem that the emperor has few clothes.
1
Telehealth and telecare have been relentlessly
plugged in the Health Service Journal for the
past year or so in a succession of features, some
accompanied by the sector manufacturing the
technology. At no point did the journal have an
open, balanced BMJ style head to head debate so
that the sceptics could have their say and restore
balance to the narrative.
Despite the Department of Health being the
sponsor of the Whole Systems Demonstrator
(WSD) trial, the government selectively revealed
the more positive pieces of data from this work
before it had been published in a peer reviewed
journal, accompanied by exhortations now we
know that it works to adopt at pace and scale.
This showed little respect for the integrity of the
research process. There has been an unseemly
rush to push us towards a 3 million lives uptake
of the technology (why 3 million?), perhaps
driven by a too cosy relationship with the limited
companies that manufacture it. Meanwhile
technologies that do have a substantial,
mature body of peer reviewed evidence base
behind them, such as comprehensive geriatric
assessment for frail older people,
2
are not
promoted with the same, concerted vigour,
perhaps because there is no margin to be made
from them for the medical industrial complex.
I note that the WSD researchers pointedly
distanced themselves from some of the early
spinning of the findings
3
and that respected
commentators have expressed similar
concerns.
/
5
And of course, they knew what
subsequent WSD results would go on to show. I
do not claim that these technologies could not
provide a range of benefits. But to promote a
policy, commission research to support it, and
then prematurely over-claim the benefits is an
abuse of research process. Better to say we are
innovating because we think its a good idea.
Even then, in a time of austerity in health and
social care, there is surely an onus to commission
services that are known to work before innovating
for its own sake.
David Oliver visiting professor of medicine for older
people, City University, London, UK
david.oliver.1@city.ac.uk
Competing interests: None declared.
1 Henderson C, Knapp M, Fernndez J-L, Beecham J, Hirani
SP, Cartwright M, et al; for the Whole System Demonstrator
evaluation team. Cost effectiveness of telehealth for patients
with long term conditions (Whole Systems Demonstrator
telehealth questionnaire study): nested economic
evaluation in a pragmatic, cluster randomised controlled
trial. BMJ lu1!;!/6:f1u!'. (ll March.)
l Ellis G, Whitehead MA, Robinson D, ONeill D, Langhorne
P. Comprehensive geriatric assessment for older adults
admitted to hospital: meta-analysis of randomised
controlled trials. BMJ lu11;!/!:d6''!.
! Steventon A. Rapid responses. Re: Effect of telehealth on
use of secondary care and mortality: findings from the
Whole System Demonstrator cluster randomised trial. bmj.
com lu1l. l August. www.bmj.com/content/!///bmj.
e!37/?tab=responses.
/ Greenhalgh T. Whole System Demonstrator trial: policy,
politics, and publication ethics. BMJ lu1l;!/':e'l3u.
' McCartney M. Show us the evidence for telehealth. BMJ
lu1l;!//:e/69.
Cite this as: BMJ ;:f
DRUG COMBINATION FOR OBESITY
First do no harm with anti-
obesity and other drugs
We welcome the decision by the European
Medicines Agency to refuse marketing
authorisation for the fixed dose combination of
topiramate (an antiepileptic) and phentermine
(an appetite suppressant amphetamine).
1
The loss of a few kilograms cannot justify
exposing patients to the known adverse effects
of the two drugs combined, such as psychiatric
disorders, cardiac arrhythmias, and metabolic
acidosis.
2
Yet, given the attractiveness of the
antiobesity market, submissions for marketing
approval are expected for other similarly
dangerous appetite suppressants, such as
lorcaserin, lisdexamfetamine, liraglutide, and
combined bupropion-naltrexone.
3
The EMA has clearly prioritised patient safety
and public health by saying no to this hazardous
combination and issuing a diametrically opposed
recommendation to that of the US Food and Drug
Administration.
But plenty of other risky drugs are under review
by the EMA, including the respiratory stimulant
almitrine, the anti-inflammatory diclofenac,
the antiemetic domperidone, the anti-anaemia
iron dextran, the benzodiazepine tetrazepam,
BMJ | 1 JUNE 2013 | VOLUME 346 23
LETTERS
strontium.
5
For calcium, the MHRA recommended
that no changes to prescribing practice were
needed. It concluded that calcium should be
prescribed to postmenopausal women who
receive treatment for osteoporosis unless
the prescriber was confident that the patient
had an adequate calcium intake
5
in effect, a
recommendation to continue the widespread
prescribing of calcium supplements.
We disagree with the MHRAs interpretation
of our analyses. We are particularly worried that,
by dismissing safety concerns about calcium
supplements that it acknowledges are legitimate,
the MHRA is endorsing clinical practice that
causes net harm. The MHRA should be consistent
in its handling of these matters and show the
same concern for the welfare of potential calcium
users as it does for those taking strontium.
Mark J Bolland senior research fellow , Department of
Medicine, University of Auckland, Private Bag 9l
u19, Auckland 11/l, New Zealand
m.bolland@auckland.ac.nz
Alison Avenell clinical research fellow , Health
Services Research Unit, University of Aberdeen,
Aberdeen ABl' lZD, UK
Andrew Grey associate professor
Ian R Reid distinguished professor , Department of
Medicine, University of Auckland, Private Bag 9l
u19, Auckland 11/l, New Zealand
Competing interests: None declared.
Full response with link to correspondence with the MHRA at
www.bmj.com/content/3/2/bmj.d2u/u/rr/6//631 .
1 Medicines and Healthcare Products Regulatory Agency.
Strontium ranelate (Protelos): risk of serious cardiac
disordersrestricted indications, new contraindications,
and warnings. Drug Safety Update lu1! ; 6 : S1 .
l ODonnell S, Cranney A, Wells GA, Adachi JD, Reginster
JY. Strontium ranelate for preventing and treating
postmenopausal osteoporosis. Cochrane Database Syst Rev
luu6 ; ! : CDuu'!l6 .
! Reid IR, Bolland MJ, Grey A. Effect of calcium
supplementation on hip fractures. Osteoporos Int
luuS ; 19 : 1119 -l!.
/ Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR.
Calcium supplements with or without vitamin D and risk of
cardiovascular events: reanalysis of the Womens Health
Initiative limited access dataset and meta-analysis. BMJ
lu11 ; !/l : dlu/u .
' Medicines and Healthcare Products Regulatory Agency.
Calcium and vitamin D: studies of cardiovascular risk do
not support prescribing changes. Drug Safety Update
lu11 ; ' : H1 .
Cite this as: BMJ 2013;346:f3413
SHARING DATA FROM CLINICAL TRIALS
Should we always share data?
Not many clinicians or scientists would argue with
the campaign by AllTrials to register and report
the full methods and results of clinical trials.
1
But
is it sensible to go so far as to encourage authors
of all BMJ papers to share their datasets publicly,
so that all may see?
2
We routinely reassure participants in clinical
trials that their data will be held securely and
confidentially. Research ethics committees rightly
insist on locked filing cabinets and ensuring that
only the researchers have access to digital data. Is
this reassurance consistent with public release of
patients confidential data without their consent?
Although only anonymised data are proposed
for public release, are data truly anonymous when
details of age, sex, and perhaps locality are linked
to past and current medical details?
And what will potential trial participants of the
future think of the reassurance of confidentiality
when they know that their anonymised data will
be publicly available for anyone to access? Will
this encourage more patients to take part in trials
or will it have the opposite effect?
I prefer the Medical Research Councils current
policy on access to research data. The council
considers release only to bona fide researchers,
who work for bona fide research organisations,
and who sign up to the same standards of
respecting the confidentiality of the data as did
the original researchers.
3
Peter D White professor of psychological medicine ,
Queen Mary University London, St Bartholomews
Hospital, London EC1A 7BE, UK p.d.white@qmul.ac.uk
Competing interests: PDW has received several Freedom of
Information requests from members of the public for all the
data from a recent trial of non-pharmacological treatments of
chronic fatigue syndrome.
1 Groves T, Godlee F. The European Medicines Agencys plans for
sharing data from clinical trials. BMJ lu1! ; !/6 : fl961 . (S May.)
l AllTrials. All trials registered. All results reported. www.
alltrials.net .
! Medical Research Council. Data sharing requirements
for population and patient studies. www.mrc.ac.uk/
Ourresearch/Ethicsresearchguidance/Datasharing/policy/
PHSpolicy/requirements/index.htm .
Cite this as: BMJ 2013;346:f3379
MONITORING THE SAFETY OF DEVICES
Tracking devices with bar codes
is a start
The important matter of obtaining high quality
routine data to monitor the safety of devices
and procedures is worthy of urgent action and
debate.
1
Device tracking is certainly a start. All devices
should be bar coded. For inpatients, the bar code
should be scanned and added to the procedure
(or a new) field in the computerised data. This has
several benefits:
It facilitates recall: centrally held computer
records are easy to scan if and when required
The cost of additional data collection is
minimised. No new registry needs to be
established and the only additional cost is
that of setting up scanning facilities at relevant
locations. These facilities should ideally be
where the devices are inserted, but they
could be located centrally in patient records
departments
Any researcher who wants to track particular
types of devices as a special research project,
on a regular basis, or as part of other research
could gain access to the data
Keeping a record of which specic devices
have been inserted also improves costing of
procedures.
Stephen Duckett director, health programme ,
Grattan Institute, Melbourne, Vic, Australia
stephen.duckett@grattan.edu.au
Competing interests: None declared.
1 Campbell B, Stainthorpe AC, Longson CM. How can we get
high quality routine data to monitor the safety of devices
and procedures? BMJ lu1! ; !/6 : fl7Sl . (7 May.)
Cite this as: BMJ 2013;346:f3380
ADULTERATION OF THE FOOD CHAIN
Fake meat scandals add to
Chinese food fears
First there
were 2u uuu
dead pigs
floating down
the Huangpu
river,
1
a main
source of water
for Shanghai
city. That was
followed by
thousands of
dead ducks
in the Nanhe river in the southwest province
of Sichuan. Dead pigs and ducks had been
used in the production of fake meat. Farmers in
Fujian province who were contracted to destroy
diseased pigs have been detained for allegedly
selling the carcasses collected from farms
and roadsides to restaurants in neighbouring
provinces.
Now the Ministry of Public Safety says that it has
apprehended meat traders in eastern China who
were passing rat off as lamb. The police arrested
63 suspects accused of selling rat labelled as
lamb for more than $1.6m (1.1m; t1.2m). As
well as the scandals involving pigs, ducks, and
lamb, the Public Security Ministry says there have
been at least another 1u meat scandals recently
involving cattle and chickens. If this state of affairs
does not change, the consequences of similar
cases could be extremely serious.
Meat smuggling and food adulteration are
rampant in China. In these cases, the suspects are
accused of using gelatin, red pigment, and nitrates
to alter the dead pigs, ducks, and rats. Chinese
food production is now on a larger scale and more
technological, and sophisticated technology
is being used to beat regulators and cheat
customers. Tainted meats are an ongoing problem.
Chinas government says it is making food safety a
top priority in the first year of president Xi Jinpings
leadership.
Cong Dai ward doctor congdai2uu6@sohu.com
Min Jiang professor, department of gastroenterology ,
First Al liated Hospital, China Medical University,
Heping District, Shenyang City, Liaoning Province,
Peoples Republic of China
Competing interests: None declared.
1 Liu CY, Hua J. Dead pigs scandal questions Chinas public
health policy. Lancet lu1! ; !S1 : 1'!9 .
Cite this as: BMJ 2013;346:f3385
C
H
I
N
A
F
O
T
O
P
R
E
S
S
/
G
E
T
T
Y
I
M
A
G
E
S
24 BMJ | 1 JUNE 2013 | VOLUME 346
OBSERVATIONS
Following in the footsteps of John the
Baptist, Ive eaten honeyed locusts,
although in my case from a tin. Ive
sucked formic acid directly from the
abdomens of green ants (quite lemony
in flavour). And Ive devoured sorrel
leaves with a paste made of crickets at
Noma, a Copenhagen restaurant.
Far from such gastronomic
exhibitionism setting me apart from
the rest of humanity, it places me
firmly with the majority. According
to Dutch entomologist Marcel Dicke,
more than half the worlds population
consumes insectsnot out of
necessity, but because they regard
them as delicacies. Dicke was on hand
at Exploring the Deliciousness of
Insects, an evening organised by the
Wellcome Collection, London. While
he provided the theory, the Nordic
Food Lab, set up by Nomas founders,
provided the practice.
Dickes message was that insects are
nutritionally rich and low in production
resource, which matters in a world
where the population is steadily
increasing, people are eating more
meat, and % of agricultural land
is being used for grazing. Traditional
supplies of animal protein soon wont
be able to keep up with demand. Could
insects be the answer?
In an update of his TED talk,
Dicke says of the planets six million
species of insects about are
eaten. We already consume insect
products: crab sticks and Campari
depend for their colour on cochineal,
derived from insects that live off cacti.
But its time we moved on to the insects
themselves, Dicke believes, reeling off
the advantages.
Firstly, insects are far enough away
from us genetically that were unlikely
to acquire their diseases by eating
thema risk with eating mammals
such as pigs and cows. Secondly,
theres the favourable conversion
factor: kg of feed yields only kg
of beef compared with kg of locust.
With cows, much of the remaining
kg is manure. By comparison, insects
produce less manure, carbon dioxide,
other greenhouse gases, and ammonia
en route to making protein.
Departments of Medicine, VA
Boston Healthcare System and
Boston University School of
Medicine, Boston, MA and
National Center for Occupational
Health and Infection Control, Office
of Public Health, Veterans Health
Administration, Gainesville, FL
, USA
Barbara W Trautner
SUMMARY POINTS
Recurrent urinary tract infection is common in otherwise healthy women
Use of products containing spermicide and sexual intercourse increase the risk of recurrences
No studies have shown that hygiene, direction of wiping, or tightness of clothing increase
the risk of recurrence
Management can include self initiated antibiotics for each episode but depends on good
communication between patient and physician
Recurrences can be prevented with regular low dose antibiotics. The choice and dose of
antibiotic should be decided on the basis of previous infections and local microbiological
guidance and availability of antibiotics
Non-antimicrobial prevention strategies are promising but have not yet been shown to be as
effective as antimicrobial prophylaxis
Follow the linkfrom the
online version of this article
to obtain certied continuing
medical education credits
SOURCES AND SELECTION CRITERIA
We searched PubMed for each topic heading. Only
articles available in English were included. Cochrane
and other expert reviews were also studied for relevant
references. Recurrent urinary tract infection (UTI) has been
investigated with high quality clinical trials, so the quality
of evidence is generally strong. Most of the comments on
risk factors, epidemiology, and overall management are
derived from observational studies and expert opinion.
Recommendations from evidence based guidelines from
the Infectious Diseases Society of America, European
Society of Clinical Microbiology and Infectious Diseases,
Society of Obstetricians and Gynaecologists of Canada,
and the Canadian Urological Association are also included.
Most antimicrobial treatment recommendations are
derived from randomized clinical trials and evidence
based guidelines. Data on management of recurrent
UTI in women with diabetes and non-antimicrobial
approaches to prophylaxis of recurrence are sparse, and
recommendations on these topics are less robust.
BMJ | 1 JUNE 2013 | VOLUME 346 31
CLINICAL REVIEW
experts r ecommend postcoital voiding because it removes
uropathogens from the urethra and is a low risk practice.
12
Genetic factors also seem to play a role in a womans
susceptibility to recurrent UTI. A history of hrst UTI occur-
ring before 15 years of age and a maternal history of UTI
are independent risk factors for recurrence.
4
A case-control
study in 431 women with recurrent UTI found that a history
of the disease in the womans mother, sister, or daughter
was associated with recurrent UTI, and having a hrst degree
female relative who experienced hve or more UTIs was also
associated with recurrent disease.
8
In cases, 70.9% reported
one or more female relative with cystitis, compared with
42.4% of controls without recurrent UTI. Variations in the
innate immune response, including polymorphisms in the
toll-like receptors that recognize pathogens in the urinary
tract, are associated with adult susceptibility to recurrent
UTI.
7
Women who are non-secretors of certain blood group
antigens may be at higher risk for Escherichia coli binding to
their uroepithelial cells and thus at higher risk for recurrent
UTI.
13
CXC chemokine receptors are also implicated. The
expression of these receptors on neutrophils is essential for
proper activation and migration of neutrophils to the site of
infection. Low CXCR1 expression has been linked to recur-
rent pyelonephritis,
14
and low CXCR1 and CXCR2 were iden-
tihed in premenopausal women with recurrent disease.
15
Ongoing advances in molecular techniques and personal-
ized genomic studies are likely to facilitate greater under-
standing of the genetic predisposition to recurrent UTI.
In postmenopausal women, incontinence, premenopau-
sal history of UTI, non-secretor status, and residual urine
aher voiding have been associated with recurrent disease
in well conducted case-control studies.
16
17
In a study of
149 postmenopausal women with recurrent disease versus
53 age matched controls, women with recurrent UTI had
higher postvoid residual volume (23% recurrent UTI v 2%
control; P <0.001) and reduced urine ow (45% recurrent
uncomplicated UTI v 23% control; P=0.004).
17
Postmeno-
pausal women also have a relative depletion of vaginal
lactobacilli and an increase in vaginal E coli compared with
premenopausal women. This age related alteration of the
normal vaginal ora, especially loss of hydrogen peroxide
producing lactobacilli, may predispose women to introital
colonization with E coli and also to UTI.
18
When should you consider underlying urinary tract
disease in recurrent UTI?
Guidance on when to refer women for further evaluation
of recurrent disease is based mainly on expert opinion and
clinical judgment. There are no randomized trials of refer-
ral versus no referral to identify robust factors associated
with anatomical abnormalities that would warrant further
evaluation.
Observational studies of women who have been referred to
urological specialists have shown that cystoscopy and imag-
ing have limited value in women with recurrent UTI. A study
of 100 women referred to urology for recurrent disease found
no abnormalities on cystoscopy except conhrmation of cys-
titis.
19
These hndings conhrmed those of similarly designed
studies.
20
A retrospective database evaluation of 118 women
with a mean age of 55 years who were referred for cystoscopy
found that nine (8%) had an abnormality including uretheral
stricture or bladder calculus or hstula.
21
In this study, nega-
tive imaging by ultrasound or computed tomography was
highly predictive of negative hndings on cystoscopy (99%).
Clinical factors that may be indications for further inves-
tigation, including imaging and referral, are outlined by
the Canadian urological guidelines.
12
The guidelines rec-
ommend further evaluation of recurrent disease in women
with a history of urinary tract surgery, known anatomical
abnormalities, immunocompromise, calculi, urea splitting
or multidrug resistant organisms, documented abnormali-
ties of ow, pneumaturia, fecaluria, or persistent gross
hematuria or asymptomatic microscopic hematuria aher
treatment of acute cystitis. Again, these recommendations
are mainly based on expert opinion.
Clinically, if recurrence occurs within two weeks of a pre-
vious episode, it is classihed as a relapse, which suggests
failure of the initial therapy, either because of antimicro-
bial failure or a persisting nidus of infection. A urine cul-
ture should be performed in these patients to show that the
drug was active against the uropathogen. Further referral
or imaging should be considered if the woman meets any
of the criteria above or if there is clinical deterioration.
12
Which organisms are responsible for recurrent UTI?
The pathogenesis of recurrent UTI is similar to that of spo-
radic infection, and 68-77% of recurrences caused by E coli
involve strains genetically indistinguishable from those that
caused previous infections.
22
23
Prospective studies have
shown that the same E coli strain can cause recurrence one
to three years later, even with negative urine cultures in
between the initial infection and the recurrence. This hnd-
ing supports the idea of a vaginal or rectal reservoir for the
causative organisms, with recurrence occurring when the
uropathogen from the intestinal ora colonizes the periu-
rethral area and ascends into the bladder. An alternative
and more recent hypothesis stemming from animal experi-
ments is that bacteria invade and persist within the bladder
epithelium and cause recurrences by re-emerging into the
bladder. Intracellular niches of infecting organisms within
the bladder epithelium have been shown in mouse models
of UTI, but the importance of this phenomenon in humans
is unclear. This concept raises the question of whether char-
acteristics of the bacterial strain itself, such as propensity for
cellular invasion, predispose the host to recurrent disease.
24
How do you diagnose recurrent UTI and confirm the diagnosis?
The clinical presentation of recurrent UTI is the same as
for sporadic acute cystitis. Local genitourinary symptoms
of dysuria, frequency, and urgency or hesitancy come on
suddenly. Gross hematuria and suprapubic pain may also
be present as part of uncomplicated cystitis. The symptoms
are ohen the same as in previous episodes; ambulatory
women with recurrent, uncomplicated UTI have a high
accuracy of correct self diagnosis.
3
Although a urine culture is not usually needed to diag-
nose sporadic cystitis, expert opinion suggests that urine
culture is useful in women presenting with recurrent dis-
ease, particularly if no culture was obtained previously.
12
The purpose of the urine culture is to conhrm the diagno-
sis and direct antimicrobial therapy. This is important in
recurrent disease to distinguish infection from overactive
bmj.com
Previous articles in this
series
Investigation and
treatment of imported
malaria in non-endemic
countries
(BMJ lu1!;!/6:fl9uu)
Safeguarding adults at
risk of harm
(BMJ lu1!;!/6:fl716)
Acne vulgaris
(BMJ lu1!;!/6:fl6!/)
Adolescent idiopathic
scoliosis
(BMJ lu1!;!/6:fl'u3)
Diagnosis and
management of
hidradenitis suppurativa
(BMJ lu1!;!/6:fl1l1)
32 BMJ | 1 JUNE 2013 | VOLUME 346
CLINICAL REVIEW
bladder or interstitial cystitis, both of which can present
with urgency and bladder discomfort.
In observational
studies of recurrent disease, E coli still predominates, but
the likelihood of a resistant uropathogen or a non-E coli
pathogen is increased.
Do not routinely oer drug interventions to treat
social anxiety disorder in children and young people.
Overcoming barriers
The guideline deals with several potential barriers to peo-
ple seeking treatment for social anxiety disorder: people
may think that the social anxiety is part of their personal-
ity and cannot be changed (or, in the case of children, that
they will grow out of it); they may fear negative evalu-
ation by healthcare professionals if they disclose their
problem; even aer presentation, the disorder may not be
recognised by healthcare professionals, especially in pri-
mary care.
).
Do not routinely oer group CBT in preference
to individual CBT. Although there is evidence
that group CBT is more eective than most other
interventions, it is less clinically and cost eective
than individual CBT.
Second line treatments
For adults who decline CBT and wish to consider
another psychological intervention, oer CBT based,
supported self help.
For adults who decline cognitive behavioural
interventions and express a preference for a drug
intervention, discuss their reasons for declining
bmj.com Previous
articles in this series
Long term follow-up
of survivors of childhood
cancer: summary of
updated SIGN guidance
(BMJ lu1!;!/6:f119u)
Recognition,
intervention, and
management of antisocial
behaviour and conduct
disorders in children and
young people: summary
of NICE-SCIE guidance
(BMJ lu1l;!/6:f1l93)
Fertility (update):
summary of NICE
guidance
(BMJ lu1!;!/6:f6'u)
Recognition and
management of psychosis
and schizophrenia in
children and young
people: summary of NICE
guidance
(BMJ lu1!;!/6:f1'u)
Ectopic pregnancy and
miscarriage: summary of
NICE guidance
(BMJ lu1l;!/':e31!6)
36 BMJ | 1 JUNE 2013 | VOLUME 346
PRACTICE
EASILY MISSED?
Acute leg ischaemia
Stephen Brearley
Whipps Cross University Hospital,
London E11 1NR, UK
vascusurg@btconnect.com
Cite this as: BMJ ;:f
doi: 1u.11!6/bmj.fl631
This is one of a series of occasional
articles highlighting conditions
that may be more common than
many doctors realise or may
be missed at first presentation.
The series advisers are Anthony
Harnden, university lecturer in
general practice, Department of
Primary Health Care, University
of Oxford, and Richard Lehman,
general practitioner, Banbury.
To suggest a topic for this series,
please email us at easilymissed@
bmj.com.
A 55 year old man consulted his general practitioner com-
plaining of persistent pain in his leh leg for three days
and a numb feeling in the foot. He was taking treatment
for hypertension, had a history of low back pain, and was
a smoker of 20 cigarettes a day. His foot looked normal,
but sensation seemed mildly reduced. The general prac-
titioner noted a weak dorsalis pedis pulse. A diagnosis
of sciatica was made, diclofenac was prescribed, and the
patient was invited to return a week later if no better. Six
days later he presented to a local emergency department
because of intolerable pain and was found to have a pro-
foundly ischaemic leh leg necessitating an above knee
amputation.
Missed diagnoses of acute leg ischaemia, as in the case
above, are common.
1
2
An analysis of data held by the
NHS Litigation Authority (NHSLA), the Medical Defence
Union (MDU), and the Medical Protection Society (MPS)
identihed 224 cases of acute leg ischaemia leading to limb
loss over a 10 year period,
1
in all of which litigation had
been initiated. Fihy one cases in which there had been
delay in detecting and treating acute limb ischaemia were
reported to the National Reporting and Learning System
(NRLS) between 2003 and 2010.
2
I have written almost
30 medicolegal reports on cases in which there were alleg-
ationsusually against general practitioners or casualty
officersof a negligent delay in diagnosing acute leg
ischaemia, ohen resulting in the avoidable loss of a limb.
What is acute leg ischaemia?
Leg ischaemia results from thrombotic, embolic, or trau-
matic arterial occlusion. It is considered to be acute if the
symptoms and signs have developed over less than two
weeks.
3
4
The term acute ischaemia does not of itself
imply severe ischaemia, but the survival of an acutely
ischaemic limb is ohen in immediate jeopardy.
2
The hall-
marks of acute ischaemia that is limb threatening are
reduced muscular power and reduced sensation in the
limb.
How common is it?
In a 1996 questionnaire survey of members of the Vascular
Surgical Society of Great Britain and Ireland, 86 out of 182
hospitals reported 539 episodes of acute lower limb ischae-
mia in a three month period.
4
In this study, acute lower
limb ischaemia was dehned as a previously stable limb
with sudden deterioration in the arterial supply for less
than two weeks. In another study, an incidence as high
as one per 7000 per annum has been quoted.
5
Medicolegal
data
1
show that over 20 legal actions are initiated each year
in the UK in relation to acute leg ischaemia, with delay in
diagnosis or treatment hguring in 73% of the claims.
Why is it missed?
In the cases reported to the NRLS, the National Patient
Safety Agency stated that causes of delay in detecting
and treating acute limb ischaemia included diagnostic
errors (such as misdiagnosis as a Bakers cyst or disc
problem, as in the case scenario), acute limb ischaemia
not being recognised as a surgical emergency, and appar-
ently inconsistent clinical diagnosis and assessment. My
own clinical and medicolegal experience indicates that
there is ohen a failure to consider a diagnosis of acute leg
ischaemia at all, especially if the patient is under 60 years
old (as in the case scenario). By no means all patients
with acute leg ischaemia have risk factors (such as atrial
hbrillation, a history of smoking, or diabetes). It should
therefore be considered in the dierential diagnosis of
all patients presenting with leg pain of sudden onset,
irrespective of age and risk factors, and all such patients
should undergo an assessment of the circulation to the
limb.
The extent to which acutely ischaemic legs are pale
(or discoloured) or cold or exhibit diminished power or
sensation is variable, and subtle changes can be missed
(as in the case above) if the examination is cursory. An
error encountered in almost all cases of missed acute leg
ischaemia, however, is that one or more doctors have
purported to feel pulses that could not possibly have
been present. Pulse palpation is an unreliable physical
sign, with false positive palpation occurring in 14% of
observations carried out by non-specialists.
6
A weak
or faint ankle pulse, or one which the doctor thinks
he or she can feel, is probably not present at all (as in the
case history above). A simple rule will protect against this
common error: If you can feel a pulse you can count it; if
you cannot count it, you are not feeling it.
Why does it matter?
Delay in diagnosis or referral was the sole or the princi-
pal cause of amputation in 59% of the patients identihed
from medicolegal data.
1
The interval between the onset of
symptoms and irretrievable damage to the leg is variable
but may be as little as six hours.
2
7
Acute leg ischaemia is
associated with an amputation rate of 13% and a mortal-
ity of 10%.
8
Both are increased by delay in diagnosis and
treatment.
8
How is it diagnosed?
Acute leg ischaemia can only be diagnosed if it is included
in the dierential diagnosis of leg pain of recent onset. It
should be considered in patients of all ages. Although
usually encountered in patients over 60 years old, rare
disorders (such as popliteal entrapment syndrome, cystic
adventitial disease, and thrombophilias) may occasion-
ally lead to its development in much younger individuals.
In all patients presenting with leg pain of sudden
onset, look for the symptoms and signs of limb threaten-
ing ischaemia as characterised by the six Ps (see box).
The patient will always have persistent pain and the ankle
pulses will always be absent. The other Ps may or may
bmj.com Previous
articles in this series
Pelvic inflammatory
disease
(BMJ lu1!;!/6:f!139)
Colorectal cancer
(BMJ lu1!;!/6:f!17l)
Delirium in older adults
(BMJ lu1!;!/6:flu!1)
Cushings syndrome
(BMJ lu1!;!/6:f9/')
Chronic exertional
compartment syndrome
(BMJ lu1!;!/6:f!!)
BMJ | 1 JUNE 2013 | VOLUME 346 37
PRACTICE
bypass).
7
In an immediately threatened limb, emergency
surgery will be required. Regrettably, some patients present
with limbs that are already dead (profound paralysis and
numbness, hxed mottling of the skin). In this situation
revascularisation may be not merely futile but harmful,
and primary amputation is necessary.
8
Contributors: The articles content was developed in discussion with J
Murray Longmore, and the hrst drah was revised in the light of comments
from Longmore.
Competing interests: I have read and understood the BMJ Group policy on
declaration of interests and have no relevant interests to declare.
Provenance and peer review: Commissioned; externally peer reviewed.
Patient consent: Patient consent not required (patient anonymised, dead,
or hypothetical).
1 Shearman A, Shearman C. Failure to diagnose acute limb ischaemia
(ALI); an avoidable cause of limb loss. Association of Surgeons of Great
Britain and Ireland, lu1l International Surgical Congress. In: www.
asgbi.org.uk/liverpoollu1l/pdfs/oral_shortpapers/Vascular_I.pdf
abstract uS1l.
l National Patient Safety Agency. Early detection and treatment
of acute limb ischaemia. Signal. lu11. www.nrls.npsa.nhs.uk/
resources/?EntryId/'=1!u17l.
! Creager MA, Kaufman JA, Conte MS. Acute limb ischaemia. N Engl J Med
lu1l;!66:l19S-lu6.
/ Campbell WB, Ridler BMF, Szymanska TH. Current management of acute
leg ischaemia: results of an audit by the Vascular Surgical Society of
Great Britain and Ireland. Br J Surg 199S;S':1/9S-'u!.
' Trummer G, Brehm K, Siepe M, Heilmann C, Schlensak C, Beyersdorf F. The
management of acute limb ischemia. Minerva Chir lu1u;6':!19-lS.
6 Brearley S, Shearman CP, Simms MH. Peripheral pulse palpation: an
unreliable physical sign. Ann Roy Coll Surg Engl 199l;7/:169-71.
7 Earnshaw JJ. Acute ischaemia: evaluation and decision making. In:
Cronenwett JL, Johnston KW, eds. Rutherfords vascular surgery. 7th ed.
Saunders Elsevier, lu1u:l!S9-9S.
S Henke P. Contemporary management of acute limb ischaemia: factors
associated with amputation and in-hospital mortality. Semin Vasc Surg
luu9;ll:!/-/u.
9 National Institute for Health and Clinical Excellence. Lower limb
peripheral arterial disease: diagnosis and management. (Clinical
guideline 1/7.) lu1l. http://guidance.nice.org.uk/CG1/7.
not be present, depending on severity, and if present may
be subtle (as in the case above). The presence or absence
of risk factors for peripheral arterial disease is of limited
usefulness. Limb threatening ischaemia may develop in
individuals who have no known risk factors and are well
under the age of 60.
The presence of acute leg ischaemia can be quickly,
simply, and reliably conhrmed or ruled out by measuring
the ankle blood pressure with a pocket Doppler machine
and a blood pressure cu.
9
The absence of Doppler signals
indicates a threatened limb, and the patient requires emer-
gency referral to a vascular centre. Doppler assessment
can be quickly learnt, is reproducible, and is easier than
many other procedures routinely carried out in primary
care (such as funduscopy). Pocket Doppler machines are
cheap (approximately E300).
How is it managed?
If a patient has leg pain of recent onset and has impalpa-
ble pulses, immediate referral to a vascular surgical unit
is mandatory. The management undertaken there will
depend on the immediacy of the threat to the survival of
the limb. The key clinical indicators of this are the pres-
ence and severity of reduced muscular power and reduced
sensation. Depending on the urgency of the situation, the
vascular unit may carry out imaging studies of the arter-
ies supplying blood to the leg (duplex ultrasound, mag-
netic resonance angiography, computed tomographic
angio graphy or intra-arterial angiography) as a basis for
planning treatment. The options for treatment comprise
endovascular procedures (angioplasty, thrombectomy, and
intra-arterial thrombolysis) and surgery (embolectomy and
Leg ischaemiathe Ps
PainAlways present,
persistent
Pallor or cyanosis or
mottling*
Perishing with cold
(poikilothermia)*
PulselessnessAlways
present. Can you count it?
Paraesthesia or reduced
sensation or numbness*
Paralysis or reduced
power*
*May be subtle. Compare left and
right legs
ANSWERS TO ENDGAMES, p 38 For long answers go to the Education channel on bmj.com
CASE REPORT
A man with bilateral loin pain
1 Loin pain.
2 Factors that contribute to stone formation
include age, sex, genetics (such as cystinuria,
as in this case), climate, geographical location,
occupation, and diet.
3 Renal tract stones are the main cause of
loin pain. However, other causes need to
be considered. Non-enhanced computed
tomography is the ideal modality for the
investigation of loin pain.
/ Staghorn calculi are best managed by
percutaneous nephrolithotomy or nephrectomy.
PICTURE QUIZ The acute abdomen
1 The erect chest radiograph shows a pneumoperitoneum with free gas under the
diaphragm bilaterally.
2 The diagnostic sensitivity of this sign depends on its cause, varying from 8% in
perforated appendicitis to 9/% in perforated peptic ulcer disease. The overall sensitivity
of detecting gas under the diaphragm on erect chest radiography in the context of a
perforated hollow viscus is 69%.
3 Free gas on erect chest radiography in the context of acute onset abdominal pain
indicates perforation of a hollow viscus until proved otherwise. The most common
causes are perforated peptic ulcer (16%), perforated diverticular disease (16%),
perforated carcinoma (sigmoid, rectal, or caecal; 1/%), and perforation secondary to
ischaemia (1u%). Perforated appendix secondary to appendicitis is common, but is less
likely to cause a substantial amount of gas under the diaphragm.
/ The patient should be resuscitated according to advanced life support principles of
airway, breathing, and circulation (ABC), and sepsis should be treated according to
the sepsis six care bundle. When stable, computed tomography may be performed to
aid in diagnosis and guide further management; alternatively, the patient may require
an emergency laparotomy without further imaging.
5 Definitive treatment depends on the cause. Patients often need surgeryeither a
laparoscopic wash-out or laparotomy. In some instances, a confined perforation is self
limiting and can be treated non-operatively with antibiotics, bowel rest, and regular
surgical review.
STATISTICAL QUESTION
Selection bias versus allocation bias
Statements a and c are true, whereas b and d are
false.
38 BMJ | 1 JUNE 2013 | VOLUME 346
ENDGAMES
We welcome contributions that would help doctors with postgraduate examinations
OSee bmj.com/endgames for details
The effectiveness of supported self management in reducing hospital
readmissions and death in patients with chronic obstructive pulmonary
disease was evaluated. Researchers performed a randomised
controlled trial. The intervention consisted of training patients to detect
and treat exacerbations promptly, with ongoing support for 12 months.
Patients in the control group continued to be managed by their general
practitioner, hospital based specialists, or both.
Participants were patients admitted to one of six hospitals in the
west of Scotland with an acute exacerbation of chronic obstructive
pulmonary disease. In total, /6/ patients were recruited and allocated
to the treatment group using stratified randomisation based on
demographic and disease severity factors. The main outcome measures
included time until first hospital readmission or death owing to
chronic obstructive pulmonary disease. The researchers reported that
supported self management had no effect on time to first hospital
readmission or death from chronic obstructive pulmonary disease.
Which of the following statements, if any, are true?
a) The method of patient recruitment meant there was the potential for
selection bias
b) Selection bias would result if patients were selected for treatment
groups on the basis of a preference by one of the researchers
c) The randomisation of patients to treatment group minimised
allocation bias
d) The randomisation of patients to treatment group minimised
selection bias
Submitted by Philip Sedgwick
Cite this as: BMJ 2013;346:f3345
FOLLOW ENDGAMES ON TWITTER
@BMJEndgames
FOR SHORT ANSWERS See p 37
FOR LONG ANSWERS
Go to the Education channel on bmj.com
A 65 year old man presented with
a 12 month history of bilateral
flank pain but no fever or lower
urinary tract symptoms. Over the
preceding 1u years he had had
multiple interventions, including
extracorporeal shock wave
lithotripsy and ureteroscopic
laser stone fragmentation, for
cystine renal stones. He had type
2 diabetes and hypertension, and
he was also obese.
A plain radiograph showed
a large renal pelvic calculus
measuring 3./ cm in the right
kidney and a /./ cm partial
staghorn calculus projected
over the left kidney. A
dimercaptosuccinic acid scan
showed a relative function of
/7.5% for the right kidney and
52.5% for the left kidney.
A staged percutaneous
nephrolithotomy was performed
successfully on the simpler right
stone, but postoperatively he
developed pain in the right loin.
A nephrostogram showed debris
partially occluding the right
ureter, which resulted in a filling
defect; this was thought to be
a clot and it later passed.
Stone analysis confirmed
cystine stones. Three months
later a percutaneous
nephrolithotomy was undertaken
on the left side. Postoperative
recovery was uneventful and
radiography showed no residual
stones.
1 What is the most common
clinical presentation of renal
tract stones?
2 What are the causative factors
for renal tract stones?
3 What are the causes of loin pain
and what investigations are
used to differentiate them?
/ What is the best management
approach for staghorn calculi?
Submitted by Mohammed Hayat Ashrafi,
Usman Bhatty, Katie Hall, and Moeketsi
Mokete
Cite this as: BMJ 2013;346:f2850
A /5 year old woman presented to the
emergency department with an eight hour
history of sudden onset abdominal pain.
The pain was severe, sharp, and worse on
movement. She felt nauseous but had not
vomited. She had last opened her bowels earlier
that day, passing a small amount of hard stool.
Her medical history included osteogenesis
imperfecta, which caused hip pain, and for
which she took 1/u mg of oxycodone daily.
On examination she was in obvious distress.
She was tachypnoeic at 22 breaths/min and
tachycardic at 11u beats/min. Blood pressure,
peripheral oxygen saturation, and temperature
were all in the normal range. Her abdomen was
exquisitely tender to palpation, with maximum
tenderness in the right iliac fossa, localised
guarding, and percussion tenderness. Digital
rectal examination identified hard faeces in the
rectum. Bowel sounds were absent. Initial blood
tests showed haemoglobin 1/.5 g/L (reference
range 12.u-15.u), white cell count 17.51u
9
/L
(/.u-11.u), C reactive protein 5.5 mg/L (u-8).
Urea, electrolytes, and liver function tests were
normal. A venous blood gas showed a raised
lactate of /.2 mmol/L (u.5-2.u; 1 mmol/L=9.u1
mg/dL). Urgent chest radiography (in the erect
position) was performed (figure).
1 What abnormality is apparent on the erect
chest radiograph?
2 What is the sensitivity of this radiological sign?
3 What is the differential diagnosis?
/ What immediate management should be
implemented for this patient?
5 What definitive treatment options should be
considered?
Submitted by B H van Duren, M Moghul, S G Appleton, and
G I van Boxel
Cite this as: BMJ 2013;346:f2549
STATISTICAL QUESTION
Selection bias versus allocation bias
PICTURE QUIZ The acute abdomen
CASE REPORT
A man with bilateral loin pain
BMJ | 1 JUNE 2013 | VOLUME 346 39
LAST WORDS
Epilepsy is
profitable, with
lifelong multiple
medication, so
a huge range of
putatively new
drugs have been
developed to seek a
slice of the profits
There are, however, no national initia-
tives to withdraw anticonvulsant drugs.
Some of the rationale for more pre-
scribing in epilepsy is to protect against
the rare but devastating sudden unex-
pected death in epilepsy (SUDEP).
SUDEP is most commonly associated
with people with tonic-clonic epilepsy
activity, not partial non-generalised
epilepsy.
16
Undoubtedly seizure control
reduces SUDEP,
17
but there is no evi-
dence that this massive increase in anti-
epileptic treatment has had an eect on
SUDEP. Lastly, predictably, and depress-
ingly, the educational agenda of epilepsy
is a gravy train of international confer-
ences and drug industry sponsorship.
18
The numbers for antiepileptic pre-
scribing just dont stack up clinically,
demand further research, and risk over-
treatment. This is bad medicine.
Des Spence is a general practitioner, Glasgow
destwo@yahoo.co.uk
Competing interests: None declared.
Provenance and peer review: Commissioned;
externally peer reviewed.
References are in the version on bmj.com.
Cite this as: BMJ ;:f
Money is the great motivator. The anti-
convulsant drug phenytoin was recently
replaced by a generic drug, in exploita-
tion of a loophole in UK policy and
increasing the cost to the NHS by E40m.
1
Epilepsy is prohtable, with lifelong
multiple medication, so a huge range
of putatively new drugs have been
developed to seek a slice of the prof-
its. They are all pitched at the same
price, in the drug industrys tradition-
ally sham competition. Anticonvul-
sants have an additional big business
bonus, too. The industry has been
hned billions for promoting anticon-
vulsants o licence in pain and psy-
chiatry specialties.
2-6
Antiepileptic prescriptions in Eng-
land rose from seven to 17 million in
a decade, with annual costs tripling to
E389m.
7
These large rises are attribut-
able to the new antiepileptics, despite
these having no proved benefit over
older drugs such as valproate and lamo-
trigine.
8
9
Evidence is also emerging that
the new drugs are being used inappropri-
ately.
10
These prescribing patterns must
also reect increasing polypharmacy in
epilepsy. Yet monotherapy is the treat-
ment goal, and polypharmacy adds little
to control seizures.
11
12
Rapid and unexplained increases in
prescribing are a sign of over diagnosis.
So is this happening in epilepsy, espe-
cially partial or focal epilepsy? In
partial epilepsy, unlike generalised
tonic-clonic seizures, the diagnosis
is ohen only clinical,
13
with dehning
symptoms such as dj vu, detachment,
feeling frightened, memory problems,
tingling, and many more subjective
effects. All diagnoses based on self
reporting and clinical judgment are
open to overdiagnosis phenomena.
Yet there is scant epidemiological data
on changes in the prevalence of epilepsy
in adults, and concerns about overdiag-
nosis are merely anecdotal. Paradoxi-
cally, in children, for whom a diagnosis
of epilepsy is less subjective, incidence
has halved since the mid-1990s.
14
Accu-
rate diagnosis is fundamental in epilepsy
because treatment is life long, although
epilepsy ohen spontaneously resolves.
15
I tried to listen to some heart sounds
last week. Couldnt hear a thing. So an
eminent professor of medicine told me
recently. Its all quackery, you know.
This is something Id thought for
a while, but Id not heard it summed
up with such frankness. Although I
continue to teach undergraduates the
distinction between reverse and hxed
splitting of the second heart sound, I
have never detected these conditions
myself. And Ive got a strong suspicion
that most cardiologists conhdently
declare a clear case of a loud P2
only aher furtively inspecting the
echocardiogram report.
So why do we promulgate this
quackery? Perhaps its a sense of
tradition: its the way things have
always been done. Perhaps its a bit
of pride at the perceived superiority of
British medicine: We know best.
The truth is that the sensitivity of
what does it matter if we go through the
rigmarole of examination? I remember
my hrst clinical hrm as a medical
student. The consultant used to have
the nurse strip each patient naked aher
taking the history before examining
them thoroughly. He would see at most
six patients in an ahernoon.
Now the consultant is expected to see
twice as many patients, and something
has to give in the race for emciency.
The inevitable result is that the hrst
nails are already in the comn of clinical
examination. We just need to have the
courage to admit it to ourselves and,
more importantly, to our students.
Kinesh Patel is a junior doctor, London
kinesh_patel@yahoo.co.uk
Competing interests: Norgine Pharmaceuticals
paid my travel and accommodation expenses for
a conference in May .
Provenance and peer review: Commissioned; not
externally peer reviewed.
Cite this as: BMJ ;:f
such tests is atrocious. As another
example, I cant remember the last
time I felt an abdominal mass in a new
patient who turned out to have cancer,
yet I diagnose an abdominal cancer
every couple of weeks endoscopically.
We teach our students charades.
Kneeling on the oor like a supplicant
to examine the abdomen, percussing
the lung bases as part of breast
examination, and using a piece of
paper placed on outstretched hands to
check for thyrotoxicosis all hark back to
a bygone age.
These clinical tests and others had
use in an era when diagnostic tests
were unavailable or unreliable, but they
are exceptionally operator dependent,
and today they are redundant. It is no
longer acceptable to use only clinical
examination to screen for conditions,
because the miss rate is just too high.
If we plan on formal testing anyway,
FROM THE FRONTLINE Des Spence
Bad medicine: epilepsy
STARTING OUT Kinesh Patel
Is clinical examination dead?
Twitter
Follow Des Spence on
Twitter @des_spence
If we plan on formal
testing anyway,
what does it matter
if we go through
the rigmarole of
examination?
40 BMJ | 1 JUNE 2013 | VOLUME 346
MINERVA
Send comments or suggest ideas to Minerva: minerva@bmj.com
The acute abdomen
Try the picture quiz in
ENDGAMES, p
By a nice irony, systemic lupus erythematosus
first became widely known to the public when
Dr Greg House, the curmudgeonly hero of
the television series House, kept declaring
that its never lupus. For the editors of the
journal Lupus, the opposite is trueand sadly,
this also goes for patients whose lives are
completely dominated by the condition. As
with most severe chronic conditions, fatigue
is a prominent feature in systemic lupus
erythematosus, and a paper in Lupus (2u13,
doi:1u.1177/u9612u3313/869/8) shows that
levels of fatigue are closely related to levels
of pain and depression, and not to markers
of disease activity. The authors suggest that
by treating these symptoms more effectively
we should also be able to alleviate fatigue in
systemic lupus erythematosus.
The commonest reason for healthy people to
see doctors regularly is because they have
been found on two or three occasions to have
blood pressure above a certain arbitrary level.
Most of these individuals then take two or
more drugs for the rest of their lives, while
others fail to respond to three or even four and
are deemed to have resistant hypertension.
A lifetime cure and a drug free existence now
seem tantalisingly close for some of these
asymptomatic patients. Renal nerve ablation
and long term carotid baroreflex activation
are two options under investigation. In a
study in Hypertension (2u13, doi:1u.1161/
HYPERTENSIONAHA.113.u1159), researchers
looked at the effect of carotid baroreflex
activation on renal function at 12 months. They
observed a slight fall in the glomerular filtration
rate, in keeping with a sustained fall in blood
pressure. For important outcomes in the long
term, we will just have to wait.
Taking aim at the ventricular septum with a
syringe full of alcohol sounds a bit of a heart-
stopping procedure, but apparently it is done
with great success in many patients with
hypertrophic obstructive cardiomyopathy.
Results from an eight year follow-up of /7u
patients with hypertrophic obstructive
cardiomyopathy treated with alcohol septal
ablation are reported in Heart (2u13,
doi:1u.1136/heartjnl-2u12-3u3339). Survival of
these patients was actually slightly better than
that of the matched general population, and
there was a marked reduction in their symptoms.
Emollients! Children with eczema need lots of
them, and parents need to be encouraged to
use them and be given generous supplies. This
is the messagenot new, but so important
from a trial of a multifaceted support
programme for parents in BMC Dermatology
(2u13;13:7, doi:1u.1186/1/71-59/5-13-7).
Unguents! Minerva prefers that word with its
lovely cool slithery sound. Call them what
you will, but they made kids feel better, sleep
better, and use less steroid cream. And the
whole programme turned out to be cost neutral
to the NHS.
Minerva takes a rather dim view of nature,
considering it to be the enemy of doctors and
gardeners alike. A naturopath, by contrast,
is a health practitioner who applies natural
therapies, according to the College of
Naturopathic Medicine. These therapies
can range from herbal mixtures to colonic
irrigation, which is actually a phenomenon
rare in nature. In a Canadian trial published
in CMAJ (2u13, doi:1u.15u3/cmaj.12u567),
naturopaths subjected some of the more
orthodox facets of their treatment regimens
to a randomised trial to see if they reduced
cardiovascular risk factors and body mass
index more than usual care: and they did. The
natural therapies methodological failings
were not any worse than those of many similar
trials using orthodox treatments, but these
findings have given rise to lively debate in the
fraternity of evidence based medicine and
beyond.
Fish, molluscs, and crustaceans are foods for
the gods, as Minerva can testify. For mortals,
too, there can be few better pleasures than
consuming sea creatures in abundance. Now
pleasure and health do not always consort
together, but in this case they do, especially
if a suitable wine is at hand. I am not referring
to the well known cardiovascular benefits of
oily fish and alcohol, but to a recent study in
the Annals of Oncology (2u13, doi:1u.1u93/
annonc/mdt168). An analysis of the European
Prospective Investigation into Cancer and
Nutrition shows that fish consumption is
associated with a reduction in the risk of
hepatocellular carcinoma. Molluscs and
crustaceans come top, with a 1/% reduction.
The authors dont talk about wine. Never
mindfruits de mer for two please, and a
bottle of your best Chablis.
One day in July 195/ Robert Lowell opened
a window, dropped his spectacles outside,
and waited for them to shatter on the stones
of the courtyard below. So begins an essay by
Stephen James on Lowells afflicted vision
in Essays in Criticism (2u13;63:177-2u2,
doi:1u.1u93/escrit/cgtuu3)the scene here
being set in a psychiatric unit as the poet
wrestles with his overwhelming wish to die.
The fog of myopia comes as a blessed relief at
this moment in his life, but in his poetry the
eye forms a constantly changing metaphor
as indeed it does in all poetry, for every
poet knows that the eye altering alters all
(William Blake, Auguries of Innocence).
Cite this as: BMJ ;:f
An 8u year old man presented with an
infective exacerbation of chronic obstructive
pulmonary disease. His chest radiograph
revealed free air below his diaphragm. He had
no abdominal symptoms or signs. Computed
tomography confirmed intraperitoneal free air
and extensive pneumatosis coli (air within the
bowel wall). Pneumatosis coli is associated
with chronic obstructive pulmonary disease
but its pathophysiology remains unclear.
Patients are usually asymptomatic, although
submucosal blebs of air could rupture into
the peritoneal cavityas seen in this patient.
In the absence of abdominal signs, there
is no indication for surgical intervention
despite this apparently alarming radiological
appearance.
Sananda Haldar (sanandahaldar@gmail.com),
specialty registrar in clinical radiology, Samuel S
Turner, specialty registrar in general surgery, Babajide
Olubaniyi, specialty registrar in clinical radiology,
David C Howlett, consultant radiologist, Eastbourne
District General Hospital, Eastbourne BN UD, UK
Patient consent obtained.
Cite this as: BMJ ;:f